Translocation of Crohn's disease Escherichia coli across M-cells: Contrasting effects of soluble plant fibres and emulsifiers

Gut

Volumn 59, Issue 10, 2010, Pages 1331-1339

  Roberts, Carol L ^a   Keita, Åsa V ^b   Duncan, Sylvia H ^c   O'Kennedy, Niamh ^d   Söderholm, Johan D ^b   Rhodes, Jonathan M ^a   Campbell, Barry J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LINKÖPING UNIVERSITY   (Sweden)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

^d PROVEXIS PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EMULSIFYING AGENT; NON STARCH POLYSACCHARIDE; POLYSACCHARIDE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM ISOLATE; BROCCOLI; CELL CULTURE; CELL STRAIN CACO 2; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIETARY FIBER; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE VILLUS; MALE; MUCOSA CELL; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RAJI CELL; SALMONELLA TYPHIMURIUM; SHIGELLA SONNEI; TRANSMISSION ELECTRON MICROSCOPY; BRASSICA; CACO 2 CELL LINE; COCULTURE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; LARGE INTESTINE; METABOLISM; MICROBIOLOGY; PHARMACOLOGY; PHYSIOLOGY; PLANTAGO; TUMOR CELL CULTURE;

BACTERIAL TRANSLOCATION; BRASSICA; CACO-2 CELLS; COCULTURE TECHNIQUES; CROHN DISEASE; DIETARY FIBER; EMULSIFYING AGENTS; ESCHERICHIA COLI; HUMANS; INTESTINAL MUCOSA; INTESTINE, LARGE; PEYER'S PATCHES; PLANTAGO; POLYSACCHARIDES; TUMOR CELLS, CULTURED;

EID: 77957201539     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.195370     Document Type: Article

References (39)

1. Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 2009;3:513-34.
2. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.
3. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43:S85-93.
4. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007;(3):CD005984.
5. Knight P, Campbell BJ, Rhodes JM. Host-bacteria interaction in inflammatory bowel disease. Br Med Bull 2008;88:95-113.
6. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
7. Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998;115:281-6.
8. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 2002;292:185-93.
9. Boudeau J, Glasser AL, Masseret E, et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999;67:4499-509.
10. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001;69:5529-37.
11. Subramanian S, Roberts CL, Hart CA, et al. Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother 2008;52:427-34.
12. Subramanian S, Rhodes JM, Hart CA, et al. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis 2008;14:162-75.
13. Meconi S, Vercellone A, Levillain F, et al. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cell Microbiol 2007;9:1252-61.
14. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn's disease-detection by laser capture microdissection and PCR. Am J Gastroenterology 2004;99:1539-43.
15. Liu Y, van Kruiningen HJ, West AB, et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995;108:1396-404.
16. Fujimura Y, Kamoi R, Iida M. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 1996;38:724-32.
17. Rickert RR, Carter HW. The "early" ulcerative lesion of Crohn's disease: correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol 1980;2:11-19.
18. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189-203.
19. Neutra MR. M cells in antigen sampling in mucosal tissues. Curr Top Microbiol Immunol 1999;236:17-32.
20. Secott TE, Lin TL, Wu CC. Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge with host integrins. Infect Immun 2004;72:3724-32.
21. Jensen VB, Harty JT, Jones BD. Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches. Infect Immun 1998;66:3758-66.
22. Owen RL, Pierce NF, Apple RT, et al. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis 1986;153:1108-18.
23. Blanco LP, DiRita VJ. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system. Cell Microbiol 2006;8:982-98.
24. Silva MA. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm Bowel Dis 2009;15:436-53.
25. Sugano M. Characteristics of fats in Japanese diets and current recommendations. Lipids 1996;31(Suppl):S283-6.
26. Freel RW, Hatch M, Earnest DL, et al. Role of tight-junctional pathways in bile salt-induced increases in colonic permeability. Am J Physiol 1983;245:G816-23.
27. Dimitrijevic D, Shaw AJ, Florence AT. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J Pharm Pharmacol 2000;52:157-62.
28. Zordan-Nudo T, Ling V, Liu Z, et al. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res 1993;53:5994-6000.
29. Friche E, Jensen PB, Sehested M, et al. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun 1990;2:297-303. (Pubitemid 20380453)
30. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-7.
31. Keita AV, Gullberg E, Ericson AC, et al. Characterisation of antigen and bacterial transport in the follicle-associated epithelium of human ileum. Lab Invest 2006;86:504-15.
32. Fujimura Y, Hosobe M, Kihara T. Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsy. Dig Dis Sci 1992;37:1089-98.
33. Shikuwa S, Isomoto H, Mizuta Y, et al. Magnifying videoendoscopic findings of Peyer's patches in the terminal ileum of Crohn's disease. Gut 2007;56:894-5.
34. Keita AV, Salim SY, Jiang T, et al. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J Pathol 2008;215:135-44.
35. Velin AK, Ericson AC, Braaf Y, et al. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut 2004;53:494-500.
36. Food and Agriculture Organisation/World Health Organisation (FAO/WHO) Expert Committee on Food Additives. Toxicological evaluation of some food additives including anticaking agents, antimicrobial, antioxidants, emulsifiers and thickening agents. WHO Food Additives Sedrioes 1974;5:254-63.
37. Culver PJ, Wilcox CS, Jones CM, et al. Intermediary metabolism of certain polyoxyethylene derivatives in man. I. Recovery of the polyoxyethylene moiety from urine and faces following ingestion of polyoxyethylene (40) mono-stearate. J Pharmacol Exp Ther 1951;103:377-81.
38. Atuma C, Strugala V, Allen A, et al. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001;280:G922-9.
39. Leiper K, Woolner J, Mullan MM, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 2001;49:790-4.